HIV-1
Clinical trials for HIV-1 explained in plain language.
Never miss a new study
Get alerted when new HIV-1 trials appear
Sign up with your email to follow new studies for HIV-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Simpler HIV treatment tested specifically for trans women
Disease control Recruiting nowThis study is testing whether a simpler, two-drug HIV treatment works well for transgender women who already have their virus under control with standard three-drug therapy. Researchers will switch 50 participants to the two-drug combination and follow them for 48 weeks to see if…
Matched conditions: HIV-1
Phase: PHASE4 • Sponsor: UBATEC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test 'Living Drug' designed to hunt hidden HIV
Disease control Recruiting nowThis is an early safety study testing a new type of cell therapy for people living with HIV. Researchers are modifying a person's own immune cells to help them find and potentially eliminate cells hiding the HIV virus, even while on standard medication. The main goal is to see if…
Matched conditions: HIV-1
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
First-of-its-Kind trial gives newborns antibody shots to block HIV
Prevention Recruiting nowThis study is testing the safety of two lab-made antibodies, given as shots to newborns who were exposed to HIV during birth. The goal is to see if these antibodies are safe for infants and to measure how long they stay in the body. Researchers will give the antibodies to 48 heal…
Matched conditions: HIV-1
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC